Clinical trial: seven-day vonoprazan- versus 14-day proton pump inhibitor-based triple therapy for first-line Helicobacter pylori eradication.
Ang D, Koo SH, Chan YH, Tan TY, Soon GH, Tan CK, Lin KW, Krishnasamy-Balasubramanian JK, Wong YJ, Kumar R, R R, Tan Y, Ong PJ, Tan YJ, Li JW, Kwek AB, Ang TL.
Ang D, et al.
Aliment Pharmacol Ther. 2022 Aug;56(3):436-449. doi: 10.1111/apt.17070. Epub 2022 Jun 3.
Aliment Pharmacol Ther. 2022.
PMID: 35665947
Clinical Trial.